Prudential Financial (PRU)
NYSEFinancialsInsurance - LifeSnapshot 2026-10-29
$116.87+1.30%
Close 2026-10-29 · 1-day change
NYSEFinancialsInsurance - LifeSnapshot 2026-10-29
Research Workspace
Put PRU beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Net income recovers above $597M: Net income: $985M.
View ThesisRevenue is growing steadily — about 9% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationRelatively steady — typically moves about 1% a day.
View RiskPRU’s case rests on earnings recovery, but its recent financial performance remains weak. Revenue grew 8% year over year in Q2 2026, and non-GAAP EPS beat by 19.3%. PRU trades at 1× book value, matching its 1× peer median. Expectations look modest versus our view, despite no valuation gap to peers. Japan’s sales suspension and governance concerns threaten customer trust; our model puts next-quarter miss odds near 22%. The net-income recovery pillar is under pressure, despite net income of $985M. Peer multiples imply a price about 11% above where it trades (it looks cheap on this basis); the thesis is on watch, and this read is provisional.
Trailing returns as of 2026-10-29. PRU is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 18 analysts currently covering PRU (as of Oct 2026).
Based on 7 Wall Street analysts offering 12-month price targets for PRU in the last 4 months.
Continue this research
Compare PRU with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| PRU Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Life & Health Insurance — fair value, gap to price, and forward P/E.
Compare the value case
Put PRU next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Reuters reports a $4 billion divestiture sharpening focus and supporting capital rotation.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
Current $116.87
The last 12 months of price, then the range of analyst 12-month targets from today’s $116.87.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Negative outlook revision over Japan headwinds signals meaningful pressure on prospects.
Threatens: Enhance competitive positioning in U.S. Businesses
Japan sales suspension impacts competitive positioning.
Threatens: Commitment to customer-first approach
Japan regulator's business suspension exposes significant customer and execution risks.
Threatens: Commitment to customer-first approach
Reported business-model connection to fraud raises customer-trust and oversight concerns.
Threatens: Commitment to customer-first approach
Fraud at Japan subsidiary directly challenges customer-first execution and controls.
Potential acquisition interest enhances competitive positioning.
Risk transfer supports capital rotation and strengthens balance-sheet flexibility.
